Posts Tagged: myasthenia gravis

Join us during this Season of Giving

  Click the blue button to donate via our secure online Season-of-Giving page. Your Gift Makes a Difference! Please help us raise $10,000 during this Season of Giving. With your gift, you will be improving the lives of individuals who struggle with the rare autoimmune disease called myasthenia gravis. Living with Myasthenia Gravis (MG) Sara… Read more »

Oct 25: Register Now for Emerging Therapies Webinar

Register Now! Emerging Therapies for MG Tuesday, October 25, 2022; 6:30pm Central Speaker: Pritikanta Paul, MD, University of Illinois at Chicago After years of research and clinical trials, a number of new therapies for myasthenia gravis have arrived or will do so soon. Instead of suppressing a person’s entire immune system (as with drugs like… Read more »

MG Activities of Daily Living (MG-ADL) Scale

With a disease like myasthenia that fluctuates from day to day and even more from month to month, it can be challenging to get a clear picture of a person’s illness. Your doctor can assess your myasthenia with several different tracking tools. One of these measures is called the MG Activities of Daily Living scale,… Read more »

Patient Experience with Pyridostigmine

In January 2022, an Illinois-based specialty pharmaceutical company collaborated on a project with Conquer MG to gain insights from MG patients. Conquer MG helped with study review and recruitment, and a study of 102 MG patients was conducted that addressed their use of pyridostigmine (brand name Mestinon®). Pyridostigmine is typically the first drug MG patients… Read more »

10th Annual Viking Challenge Recap

Victor Vipp a the 10th Annual Viking Challenge for MG

Viking Challenge for MG 2022 Walkers, volunteers, and sponsor reps – 110 in all – gathered on June 19, 2022, in Elmhurst, Illinois, to kick off the 10th Annual Viking Challenge for Myasthenia Gravis. It was the first in-person event for this group in two years, and each person was prepared to rally in support… Read more »